Product Reports Resources Pricing Login Book a demo

Forus

Biotech & Life Sciences · New York City, United States · Founded 2023

Automating prescription-to-approval workflows to help patients access medicine at no cost MoreLess

Forus is a healthcare technology innovator that functions as an AI-native operating system designed to bridge the gap between scientific breakthroughs and patient access. Originally founded as Tandem, the company focuses on removing the logistical and administrative obstacles that delay treatment, such as complex prior authorization processes and fragmented pharmacy routing. By providing a centralized platform that handles the end-to-end journey of a prescription, Forus aims to ensure that the "last mile" of healthcare is as efficient as the scientific research that precedes it.

The company's target market includes the entire healthcare ecosystem: patients who need faster access to medicine, clinicians who are overwhelmed by administrative documentation, and biopharma companies looking to streamline drug launches. Unlike traditional healthcare software that adds costs to providers, Forus operates on a unique model where its automation tools are provided for free to healthcare professionals. Its primary value proposition lies in reclaiming clinical time for physicians and reducing the 10-to-15-year timeline typically required to bring and distribute new drugs to market.

Forus leverages advanced artificial intelligence to manage clinical workflows both during and after patient visits. Its technology includes automated prescription writing, real-time clinical decision support, and AI-driven coding assistants that integrate seamlessly with existing Electronic Health Record (EHR) systems. By automating these "administrative" steps, Forus transforms the clinical visit from a paperwork-heavy encounter into a patient-centered experience, using data-driven insights to accelerate medical approval and delivery at a global scale.

Keywords: healthcare, automation, prescriptions, artificial intelligence, patient access, biopharma, clinical workflow, healthtech, medical approval, AI-native.

Valuation $1–2.5B
Revenue $50–100M
Headcount 100–500
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Forus and the history behind them.

Company overview

Forus company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2023
Headquarters
New York City, United States
Employees
211
Open positions
7
Dealroom signal
92.7
client focusb2btechnologyArtificial Intelligenceclient focusb2csub industryPharmaceuticalsub industryHealth PlatformsectorHealth Care Information Technologybusiness modelMarketplace & ecommercesectorMedical ProfessionalsindustryHealthsectorMedical & HealthcaresectorCore AIsectorVerified Unicorns and $1B ExitssectorTech for Hospitals and ClinicssectorTech for Medical Professionals

Valuation & funding

Forus funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
LATE VCOther financing May 2026 $123M $1B Pear Ventures · Accel · Redpoint · General Catalyst
SERIES AOther financing Jan 2024 $30M $120M BoxGroup · General Catalyst
Showing 2 recorded eventsUnlock the complete deal history →

Financials

Revenue and workforce over time

Available revenue and workforce history. Fields without reported data are omitted.

YearRevenueGrowthEmployees
2026 $50M +400% 211
2025 $10M 0% 289
2024 $10M 0% 69
2023 $10M
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Forus website traffic

Latest recorded traffic for Forus is 160K monthly website visits, up 14.3% over the last three months. Forus's team declined 27% over the past year.

Latest monthly visits160K 3-month web change+14.3% 1-year team growth-27%
Monthly website visits27 observations · May 2024–Jul 2026
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Forus compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Forus's talent

Book a demo to see the people
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Forus's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 2 investors entered at this stage

Global footprint

Where Forus has talent and traffic

Workforce by country
5 countries with
team presence
🇺🇸 United States97.5%
🇬🇧 United Kingdom1%
🇫🇷 France0.5%
🇦🇺 Australia0.5%
🇮🇳 India0.5%
5 countries shown

In the news

Latest news about Forus

Recent press, funding announcements, and product moves mentioning Forus — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Forus

An AI-synthesized read of the highest-engagement posts about Forus on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Forus’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.